nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CES1—larynx—muscle cancer	0.157	0.42	CbGeAlD
Ciclesonide—Obstructive airways disorder—Methotrexate—muscle cancer	0.0303	0.0483	CcSEcCtD
Ciclesonide—SERPINA6—renal system—muscle cancer	0.0262	0.0702	CbGeAlD
Ciclesonide—SERPINA6—bone marrow—muscle cancer	0.0198	0.0531	CbGeAlD
Ciclesonide—CES1—head—muscle cancer	0.0176	0.047	CbGeAlD
Ciclesonide—SERPINA6—head—muscle cancer	0.0175	0.047	CbGeAlD
Ciclesonide—CES1—testis—muscle cancer	0.017	0.0454	CbGeAlD
Ciclesonide—Ulcer—Dactinomycin—muscle cancer	0.0168	0.0268	CcSEcCtD
Ciclesonide—Impaired healing—Methotrexate—muscle cancer	0.0159	0.0254	CcSEcCtD
Ciclesonide—Musculoskeletal chest pain—Doxorubicin—muscle cancer	0.0154	0.0245	CcSEcCtD
Ciclesonide—NR3C1—embryo—muscle cancer	0.0152	0.0406	CbGeAlD
Ciclesonide—Laboratory test abnormal—Doxorubicin—muscle cancer	0.0143	0.0227	CcSEcCtD
Ciclesonide—Chest discomfort—Etoposide—muscle cancer	0.013	0.0207	CcSEcCtD
Ciclesonide—Osteoporosis—Methotrexate—muscle cancer	0.0123	0.0196	CcSEcCtD
Ciclesonide—Ulcer—Etoposide—muscle cancer	0.0121	0.0194	CcSEcCtD
Ciclesonide—NR3C1—smooth muscle tissue—muscle cancer	0.0119	0.032	CbGeAlD
Ciclesonide—Fracture—Methotrexate—muscle cancer	0.0118	0.0189	CcSEcCtD
Ciclesonide—Multiple fractures—Methotrexate—muscle cancer	0.0118	0.0189	CcSEcCtD
Ciclesonide—NR3C1—renal system—muscle cancer	0.0115	0.0308	CbGeAlD
Ciclesonide—Candida infection—Etoposide—muscle cancer	0.011	0.0175	CcSEcCtD
Ciclesonide—Pain in extremity—Vincristine—muscle cancer	0.0103	0.0164	CcSEcCtD
Ciclesonide—NR3C1—cardiac atrium—muscle cancer	0.0103	0.0275	CbGeAlD
Ciclesonide—Swelling—Etoposide—muscle cancer	0.00944	0.0151	CcSEcCtD
Ciclesonide—Oral candidiasis—Doxorubicin—muscle cancer	0.00937	0.015	CcSEcCtD
Ciclesonide—NR3C1—tendon—muscle cancer	0.00896	0.024	CbGeAlD
Ciclesonide—Pneumonia—Dactinomycin—muscle cancer	0.00892	0.0142	CcSEcCtD
Ciclesonide—CYP3A4—renal system—muscle cancer	0.00868	0.0233	CbGeAlD
Ciclesonide—NR3C1—bone marrow—muscle cancer	0.00868	0.0233	CbGeAlD
Ciclesonide—CYP2D6—renal system—muscle cancer	0.00855	0.0229	CbGeAlD
Ciclesonide—NR3C1—vagina—muscle cancer	0.00832	0.0223	CbGeAlD
Ciclesonide—Pneumonia—Vincristine—muscle cancer	0.00797	0.0127	CcSEcCtD
Ciclesonide—Pharyngitis—Dactinomycin—muscle cancer	0.0079	0.0126	CcSEcCtD
Ciclesonide—NR3C1—head—muscle cancer	0.00768	0.0206	CbGeAlD
Ciclesonide—NR3C1—testis—muscle cancer	0.00742	0.0199	CbGeAlD
Ciclesonide—Alanine aminotransferase increased—Etoposide—muscle cancer	0.00735	0.0117	CcSEcCtD
Ciclesonide—Ulcer—Methotrexate—muscle cancer	0.00727	0.0116	CcSEcCtD
Ciclesonide—Dysphonia—Doxorubicin—muscle cancer	0.00724	0.0115	CcSEcCtD
Ciclesonide—Bronchospasm—Etoposide—muscle cancer	0.00708	0.0113	CcSEcCtD
Ciclesonide—Pneumonia—Etoposide—muscle cancer	0.00646	0.0103	CcSEcCtD
Ciclesonide—Infestation NOS—Etoposide—muscle cancer	0.00642	0.0102	CcSEcCtD
Ciclesonide—Infestation—Etoposide—muscle cancer	0.00642	0.0102	CcSEcCtD
Ciclesonide—Mediastinal disorder—Vincristine—muscle cancer	0.00641	0.0102	CcSEcCtD
Ciclesonide—Ulcer—Doxorubicin—muscle cancer	0.00629	0.01	CcSEcCtD
Ciclesonide—Back pain—Vincristine—muscle cancer	0.00599	0.00956	CcSEcCtD
Ciclesonide—Diabetes mellitus—Methotrexate—muscle cancer	0.00574	0.00916	CcSEcCtD
Ciclesonide—CYP2D6—head—muscle cancer	0.00572	0.0153	CbGeAlD
Ciclesonide—Candida infection—Doxorubicin—muscle cancer	0.00568	0.00907	CcSEcCtD
Ciclesonide—Infection—Dactinomycin—muscle cancer	0.00562	0.00897	CcSEcCtD
Ciclesonide—CYP2D6—testis—muscle cancer	0.00552	0.0148	CbGeAlD
Ciclesonide—Hypertension—Vincristine—muscle cancer	0.00535	0.00853	CcSEcCtD
Ciclesonide—Immune system disorder—Etoposide—muscle cancer	0.00521	0.00831	CcSEcCtD
Ciclesonide—Mediastinal disorder—Etoposide—muscle cancer	0.00519	0.00829	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00515	0.00823	CcSEcCtD
Ciclesonide—Infection—Vincristine—muscle cancer	0.00502	0.00801	CcSEcCtD
Ciclesonide—Diabetes mellitus—Doxorubicin—muscle cancer	0.00497	0.00793	CcSEcCtD
Ciclesonide—Dysgeusia—Etoposide—muscle cancer	0.00491	0.00784	CcSEcCtD
Ciclesonide—Fatigue—Dactinomycin—muscle cancer	0.00488	0.00778	CcSEcCtD
Ciclesonide—Back pain—Etoposide—muscle cancer	0.00485	0.00774	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00461	0.00735	CcSEcCtD
Ciclesonide—Cough—Etoposide—muscle cancer	0.00438	0.00699	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vincristine—muscle cancer	0.00436	0.00696	CcSEcCtD
Ciclesonide—Fatigue—Vincristine—muscle cancer	0.00436	0.00695	CcSEcCtD
Ciclesonide—Hypertension—Etoposide—muscle cancer	0.00433	0.00691	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—muscle cancer	0.00432	0.0069	CcSEcCtD
Ciclesonide—Chest pain—Etoposide—muscle cancer	0.00427	0.00682	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—muscle cancer	0.00417	0.00666	CcSEcCtD
Ciclesonide—Infection—Etoposide—muscle cancer	0.00407	0.00649	CcSEcCtD
Ciclesonide—Asthenia—Dactinomycin—muscle cancer	0.00406	0.00648	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00401	0.0064	CcSEcCtD
Ciclesonide—Pneumonia—Methotrexate—muscle cancer	0.00387	0.00617	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—muscle cancer	0.00386	0.00617	CcSEcCtD
Ciclesonide—Infestation—Methotrexate—muscle cancer	0.00385	0.00614	CcSEcCtD
Ciclesonide—Infestation NOS—Methotrexate—muscle cancer	0.00385	0.00614	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00381	0.00608	CcSEcCtD
Ciclesonide—Conjunctivitis—Methotrexate—muscle cancer	0.00374	0.00597	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—muscle cancer	0.00373	0.00596	CcSEcCtD
Ciclesonide—Dyspnoea—Etoposide—muscle cancer	0.00365	0.00583	CcSEcCtD
Ciclesonide—Epistaxis—Methotrexate—muscle cancer	0.00363	0.00579	CcSEcCtD
Ciclesonide—Asthenia—Vincristine—muscle cancer	0.00363	0.00579	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—muscle cancer	0.00359	0.00573	CcSEcCtD
Ciclesonide—Rash—Dactinomycin—muscle cancer	0.00357	0.00569	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Etoposide—muscle cancer	0.00354	0.00564	CcSEcCtD
Ciclesonide—Fatigue—Etoposide—muscle cancer	0.00353	0.00563	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00347	0.00554	CcSEcCtD
Ciclesonide—Haemoglobin—Methotrexate—muscle cancer	0.00347	0.00554	CcSEcCtD
Ciclesonide—Haemorrhage—Methotrexate—muscle cancer	0.00345	0.00551	CcSEcCtD
Ciclesonide—Pharyngitis—Methotrexate—muscle cancer	0.00343	0.00547	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—muscle cancer	0.0034	0.00542	CcSEcCtD
Ciclesonide—Nausea—Dactinomycin—muscle cancer	0.00336	0.00536	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—muscle cancer	0.00335	0.00534	CcSEcCtD
Ciclesonide—Dizziness—Vincristine—muscle cancer	0.00334	0.00533	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—muscle cancer	0.00333	0.00531	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—muscle cancer	0.00333	0.00531	CcSEcCtD
Ciclesonide—Urticaria—Etoposide—muscle cancer	0.00325	0.00519	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—muscle cancer	0.00324	0.00517	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—muscle cancer	0.00324	0.00517	CcSEcCtD
Ciclesonide—Rash—Vincristine—muscle cancer	0.00319	0.00509	CcSEcCtD
Ciclesonide—Dermatitis—Vincristine—muscle cancer	0.00318	0.00508	CcSEcCtD
Ciclesonide—Headache—Vincristine—muscle cancer	0.00317	0.00505	CcSEcCtD
Ciclesonide—Epistaxis—Doxorubicin—muscle cancer	0.00314	0.00501	CcSEcCtD
Ciclesonide—Sinusitis—Doxorubicin—muscle cancer	0.00312	0.00499	CcSEcCtD
Ciclesonide—Immune system disorder—Methotrexate—muscle cancer	0.00312	0.00498	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methotrexate—muscle cancer	0.00311	0.00497	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—muscle cancer	0.003	0.00479	CcSEcCtD
Ciclesonide—Nausea—Vincristine—muscle cancer	0.003	0.00479	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—muscle cancer	0.003	0.00478	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—muscle cancer	0.00299	0.00477	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—muscle cancer	0.00297	0.00473	CcSEcCtD
Ciclesonide—Dysgeusia—Methotrexate—muscle cancer	0.00294	0.0047	CcSEcCtD
Ciclesonide—Asthenia—Etoposide—muscle cancer	0.00294	0.00469	CcSEcCtD
Ciclesonide—Back pain—Methotrexate—muscle cancer	0.00291	0.00464	CcSEcCtD
Ciclesonide—Dizziness—Etoposide—muscle cancer	0.00271	0.00432	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—muscle cancer	0.0027	0.00431	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—muscle cancer	0.00269	0.0043	CcSEcCtD
Ciclesonide—Cough—Methotrexate—muscle cancer	0.00262	0.00418	CcSEcCtD
Ciclesonide—Rash—Etoposide—muscle cancer	0.00258	0.00412	CcSEcCtD
Ciclesonide—Dermatitis—Etoposide—muscle cancer	0.00258	0.00412	CcSEcCtD
Ciclesonide—Headache—Etoposide—muscle cancer	0.00257	0.00409	CcSEcCtD
Ciclesonide—Chest pain—Methotrexate—muscle cancer	0.00256	0.00408	CcSEcCtD
Ciclesonide—Arthralgia—Methotrexate—muscle cancer	0.00256	0.00408	CcSEcCtD
Ciclesonide—Dysgeusia—Doxorubicin—muscle cancer	0.00255	0.00407	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—muscle cancer	0.00252	0.00402	CcSEcCtD
Ciclesonide—Infection—Methotrexate—muscle cancer	0.00244	0.00389	CcSEcCtD
Ciclesonide—Nausea—Etoposide—muscle cancer	0.00243	0.00388	CcSEcCtD
Ciclesonide—Palpitations—Doxorubicin—muscle cancer	0.0023	0.00367	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—muscle cancer	0.00227	0.00362	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—muscle cancer	0.00225	0.00359	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00223	0.00357	CcSEcCtD
Ciclesonide—Arthralgia—Doxorubicin—muscle cancer	0.00222	0.00354	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—muscle cancer	0.00222	0.00354	CcSEcCtD
Ciclesonide—Dyspnoea—Methotrexate—muscle cancer	0.00219	0.00349	CcSEcCtD
Ciclesonide—Dry mouth—Doxorubicin—muscle cancer	0.00217	0.00346	CcSEcCtD
Ciclesonide—Dyspepsia—Methotrexate—muscle cancer	0.00216	0.00345	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00212	0.00338	CcSEcCtD
Ciclesonide—Fatigue—Methotrexate—muscle cancer	0.00211	0.00337	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—muscle cancer	0.00211	0.00337	CcSEcCtD
Ciclesonide—Urticaria—Methotrexate—muscle cancer	0.00195	0.00311	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00193	0.00309	CcSEcCtD
Ciclesonide—Dyspnoea—Doxorubicin—muscle cancer	0.00189	0.00302	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—muscle cancer	0.00187	0.00298	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00183	0.00293	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—muscle cancer	0.00183	0.00292	CcSEcCtD
Ciclesonide—Asthenia—Methotrexate—muscle cancer	0.00176	0.00281	CcSEcCtD
Ciclesonide—Urticaria—Doxorubicin—muscle cancer	0.00169	0.00269	CcSEcCtD
Ciclesonide—Dizziness—Methotrexate—muscle cancer	0.00162	0.00259	CcSEcCtD
Ciclesonide—Rash—Methotrexate—muscle cancer	0.00155	0.00247	CcSEcCtD
Ciclesonide—Dermatitis—Methotrexate—muscle cancer	0.00155	0.00247	CcSEcCtD
Ciclesonide—Headache—Methotrexate—muscle cancer	0.00154	0.00245	CcSEcCtD
Ciclesonide—Asthenia—Doxorubicin—muscle cancer	0.00152	0.00243	CcSEcCtD
Ciclesonide—Nausea—Methotrexate—muscle cancer	0.00146	0.00232	CcSEcCtD
Ciclesonide—Dizziness—Doxorubicin—muscle cancer	0.0014	0.00224	CcSEcCtD
Ciclesonide—Rash—Doxorubicin—muscle cancer	0.00134	0.00214	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—muscle cancer	0.00134	0.00213	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—muscle cancer	0.00133	0.00212	CcSEcCtD
Ciclesonide—Nausea—Doxorubicin—muscle cancer	0.00126	0.00201	CcSEcCtD
